EdgarLookup

Silo Pharma, Inc. — All Filings

349 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 3 3/A 4 4/A 40-17G 424B3 424B4 424B5 8-A12B 8-A12G 8-K 8-K/A 8-K12B ARS CERT CORRESP D D/A DEF 14A DEF 14C DEFA14A DEFR14A DRS EFFECT N-54A N-54C NT 10-K NT 10-Q POS AM PRE 14A PRE 14C S-1 S-1/A S-3 S-3/A SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
EFFECT 9999999995-25-000965 Apr 3, 2025
10-K ANNUAL REPORT 0001013762-25-004139 Mar 28, 2025 Dec 31, 2024
POS AM POST-EFFECTIVE AMENDMENT TO FORM S-1 0001013762-25-004209 Mar 28, 2025
8-K CURRENT REPORT 0001213900-25-021916 Mar 10, 2025
8-K CURRENT REPORT 0001213900-25-021345 Mar 7, 2025 Mar 4, 2025
SCHEDULE 13G/A 0001037389-25-000019 Feb 13, 2025
8-K CURRENT REPORT 0001213900-25-000191 Jan 2, 2025
8-K CURRENT REPORT 0001213900-24-111256 Dec 20, 2024
4 0001213900-24-109363 Dec 16, 2024 Dec 13, 2024
4 0001213900-24-101610 Nov 22, 2024 Nov 20, 2024
DEFR14A PROXY STATEMENT 0001213900-24-099217 Nov 15, 2024
SCHEDULE 13G 0001037389-24-000104 Nov 13, 2024
10-Q QUARTERLY REPORT 0001213900-24-096841 Nov 12, 2024 Sep 30, 2024
DEFA14A CURRENT REPORT 0001213900-24-095888 Nov 8, 2024
8-K CURRENT REPORT 0001213900-24-095886 Nov 8, 2024
DEF 14A PROXY STATEMENT 0001213900-24-079883 Sep 18, 2024 Nov 12, 2024
DEFA14A ADDITIONAL DEFINITIVE SOLICITING MATERIALS. 0001213900-24-079885 Sep 18, 2024
ARS ANNUAL REPORT 0001213900-24-079888 Sep 18, 2024 Dec 31, 2023
8-K CURRENT REPORT 0001213900-24-077111 Sep 10, 2024
424B3 PROSPECTUS 0001213900-24-075513 Sep 4, 2024
EFFECT 9999999995-24-002709 Sep 3, 2024
CORRESP 0001213900-24-073912 Aug 29, 2024
UPLOAD 0000000000-24-009823 Aug 28, 2024
S-1 REGISTRATION STATEMENT 0001213900-24-071525 Aug 21, 2024
10-Q QUARTERLY REPORT 0001213900-24-068296 Aug 13, 2024 Jun 30, 2024
D 0001213900-24-064557 Aug 2, 2024
424B3 PROSPECTUS 0001013762-24-002808 Jul 31, 2024
EFFECT 9999999995-24-002320 Jul 30, 2024
SC 13G SCHEDULE 13G 0001013762-24-001611 Jul 26, 2024
CORRESP 0001013762-24-001490 Jul 26, 2024
S-1/A AMENDMENT NO. 1 TO FORM S-1 0001013762-24-001151 Jul 25, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-063203 Jul 22, 2024
UPLOAD 0000000000-24-008256 Jul 22, 2024
8-K CURRENT REPORT 0001013762-24-000518 Jul 22, 2024 Jul 18, 2024
S-1 REGISTRATION STATEMENT 0001213900-24-062184 Jul 17, 2024
8-K CURRENT REPORT 0001213900-24-059821 Jul 8, 2024 Jul 1, 2024
8-K CURRENT REPORT 0001213900-24-056678 Jun 27, 2024 Jun 26, 2024
SC 13G SCHEDULE 13G 0001213900-24-052491 Jun 13, 2024
4 0001213900-24-052354 Jun 13, 2024 Jun 11, 2024
D 0001213900-24-051718 Jun 11, 2024
424B5 PROSPECTUS SUPPLEMENT 0001213900-24-050186 Jun 6, 2024
8-K CURRENT REPORT 0001213900-24-050405 Jun 6, 2024 Jun 4, 2024
8-K CURRENT REPORT 0001213900-24-049658 Jun 4, 2024
10-Q QUARTERLY REPORT 0001213900-24-042299 May 13, 2024 Mar 31, 2024
4 0001213900-24-031159 Apr 8, 2024 Apr 4, 2024
8-K CURRENT REPORT 0001213900-24-030805 Apr 5, 2024 Apr 4, 2024
4 0001213900-24-028973 Apr 1, 2024 Mar 28, 2024
10-K ANNUAL REPORT 0001213900-24-025615 Mar 25, 2024 Dec 31, 2023
8-K CURRENT REPORT 0001213900-24-008888 Feb 1, 2024
EFFECT 9999999995-24-000251 Jan 30, 2024